Non-pharmaceutical interventions for pandemic influenza, international measures
- PMID: 16494722
- PMCID: PMC3291414
- DOI: 10.3201/eid1201.051370
Non-pharmaceutical interventions for pandemic influenza, international measures
Abstract
Since global availability of vaccine and antiviral agents against influenza caused by novel human subtypes is insufficient, the World Health Organization (WHO) recommends non-pharmaceutical public health interventions to contain infection, delay spread, and reduce the impact of pandemic disease. Virus transmission characteristics will not be completely known in advance, but difficulties in influenza control typically include peak infectivity early in illness, a short interval between cases, and to a lesser extent, transmission from persons with incubating or asymptomatic infection. Screening and quarantining entering travelers at international borders did not substantially delay virus introduction in past pandemics, except in some island countries, and will likely be even less effective in the modern era. Instead, WHO recommends providing information to international travelers and possibly screening travelers departing countries with transmissible human infection. The principal focus of interventions against pandemic influenza spread should be at national and community levels rather than international borders.
Similar articles
-
Influenza and SARS: the impact of viral pandemics on maritime health.Int Marit Health. 2011;62(3):170-5. Int Marit Health. 2011. PMID: 22258842
-
International travelers as sentinels for sustained influenza transmission during the 2009 influenza A(H1N1)pdm09 pandemic.J Travel Med. 2013 May-Jun;20(3):177-84. doi: 10.1111/jtm.12025. Epub 2013 Mar 14. J Travel Med. 2013. PMID: 23577864
-
[Public health measures at the airport of Hamburg during the early phase of pandemic influenza (H1N1) 2009].Gesundheitswesen. 2012 Mar;74(3):145-53. doi: 10.1055/s-0030-1270502. Epub 2011 Feb 8. Gesundheitswesen. 2012. PMID: 21305451 German.
-
A rapid review of the effectiveness of screening practices at airports, land borders and ports to reduce the transmission of respiratory infectious diseases such as COVID-19.S Afr Med J. 2020 Oct 12;110(11):1105-1109. S Afr Med J. 2020. PMID: 33403987 Review.
-
Influenza a (H1N1) outbreak and challenges for pharmacotherapy.Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):113-26. Indian J Physiol Pharmacol. 2009. PMID: 20112815 Review.
Cited by
-
Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2322660121. doi: 10.1073/pnas.2322660121. Epub 2024 Aug 6. Proc Natl Acad Sci U S A. 2024. PMID: 39361828 Free PMC article.
-
Risk factors for diarrheal diseases among pilgrims during Arba'een mass gathering: a case-control study.BMC Infect Dis. 2024 Sep 27;24(1):1063. doi: 10.1186/s12879-024-09962-1. BMC Infect Dis. 2024. PMID: 39333896 Free PMC article.
-
Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States.Infect Dis Ther. 2024 Sep;13(9):2071-2087. doi: 10.1007/s40121-024-01027-9. Epub 2024 Aug 16. Infect Dis Ther. 2024. PMID: 39150658 Free PMC article.
-
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.Influenza Other Respir Viruses. 2024 May;18(5):e13302. doi: 10.1111/irv.13302. Influenza Other Respir Viruses. 2024. PMID: 38706384 Free PMC article. Clinical Trial.
-
Risk of SARS-CoV-2 infection in dental healthcare workers - a systematic review and meta-analysis.GMS Hyg Infect Control. 2024 Mar 5;19:Doc09. doi: 10.3205/dgkh000464. eCollection 2024. GMS Hyg Infect Control. 2024. PMID: 38655123 Free PMC article.
References
-
- World Health Organization. Avian influenza: assessing the pandemic threat. 2005. [cited 2005 Jan]. Available from http://www.who.int/csr/disease/influenza/WHO_CDS_2005_29/en/index.html
-
- World Health Organization. WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. Annex 1. 2005. [cited 2005 Apr]. Available from http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_...
-
- World Health Organization. Non-pharmaceutical interventions: their role in reducing transmission and spread. 2005. [cited 2005 Nov]. Available from http://www.who.int/csr/disease/avian_influenza/pharmaintervention2005_11...
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
